Social Pulse: Bristol-Myers Squibb Co (BMY)
BMY on New York Consolidated
43.30USD
17 May 2013
43.30USD
17 May 2013
Price Change (% chg)
$0.53 (+1.24%)
$0.53 (+1.24%)
Prev Close
$42.77
$42.77
Open
$42.99
$42.99
Day's High
$43.43
$43.43
Day's Low
$42.70
$42.70
Volume
11,130,086
11,130,086
Avg. Vol
9,889,589
9,889,589
52-wk High
$45.59
$45.59
52-wk Low
$30.64
$30.64
Press Releases
- Innate Pharma (Euronext Paris: FR0010331421 - IPH): First Patient Treated in the EffiKIR Trial
- The Medicines Company and Bristol-Myers Squibb Agree to Global Alliance for Recothrom(R)
- Bristol-Myers Squibb Foundation Awards Mental Health Grants of Nearly $3 Million to Support Returning Veterans
- Elotuzumab Progression-Free Survival Data from Phase 2 Study of Patients with Previously-Treated Multiple Myeloma Presented at 54th American Society of Hematology (ASH) Annual Meeting
- ELIQUIS® (apixaban) Demonstrated Superiority In Reducing A Composite Of Recurrent Venous Thromboembolism And All-Cause Death Without Increasing The Rate Of Major Bleeding Versus Placebo During One Year Of Extended Treatment
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
